Search

Your search keyword '"Robbert J, de Winter"' showing total 570 results

Search Constraints

Start Over You searched for: Author "Robbert J, de Winter" Remove constraint Author: "Robbert J, de Winter"
570 results on '"Robbert J, de Winter"'

Search Results

51. Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)

52. Quantitative Assessment of Acute Regurgitation Following TAVR

53. Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding Events

54. 1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration

55. 1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents

56. The influence of implantation techniques on lesion oriented-outcomes in Absorb BVS and Xience EES lesions treated in routine clinical practice at complete three year follow-up: AIDA trial QCA substudy

57. A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial

58. Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trial

59. Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy

60. Non-Culprit MACE Rate in LRP: The Influence of Optimal Medical Therapy Using DAPT and Statins

61. 10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Calcification

62. Clinical Outcomes after Percutaneous Coronary Intervention for Cardiogenic Shock Secondary to Total Occlusive Unprotected Left Main Coronary Artery Lesion-Related Acute Myocardial Infarction

63. High levels of osteoprotegerin are associated with coronary artery calcification in patients suspected of a chronic coronary syndrome

64. Cardiovascular morbidity and mortality in adult patients with repaired aortic coarctation

65. TCT-346 The Mega COMBO Collaboration:An Individual Patient Data Pooled Analysis of Patients Undergoing PCI With COMBO Stent

66. One-year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real-world cohort analysis

67. Closing a Right Coronary Artery Fistula Draining Into the Coronary Sinus Using a Covered Stent in the Coronary Sinus

68. The Impact of Percutaneous Coronary Intervention on Mortality in Patients With Coronary Lesions Who Underwent Transcatheter Aortic Valve Replacement

69. Björk-Fontan and the Restoration of Right-Sided Conduits

70. Effect of anti-ApoA-I antibody-coating of stents on neointima formation in a rabbit balloon-injury model.

71. Stents Eluting 6-Mercaptopurine Reduce Neointima Formation and Inflammation while Enhancing Strut Coverage in Rabbits.

72. 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent

73. Rationale and Design of the Vasospastic Angina Treatment by Endothelin Receptor Antagonism (VERA) Trial

74. Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome

75. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI

76. A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX

77. Extracellular traps derived from macrophages, mast cells, eosinophils and neutrophils are generated in a time-dependent manner during atherothrombosis

78. Management of Patients with Patent Foramen Ovale and Cryptogenic Stroke: An Update

79. Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry

80. Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI

81. The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial

82. Efficiency of Statin Treatment on EPC Recruitment Depends on Baseline EPC Titer and Does Not Improve Angiographic Outcome in Coronary Artery Disease Patients Treated with the Genous Stent

83. Admission lipoprotein-associated phospholipase A2 activity is not associated with long-term clinical outcomes after ST-segment elevation myocardial infarction.

84. Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study

85. Time course of coronary flow capacity impairment in ST-segment elevation myocardial infarction

86. The prognostic value of automated coronary calcium derived by a deep learning approach on non-ECG gated CT images from 82Rb-PET/CT myocardial perfusion imaging

87. Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration

88. TCT-212 CT-Derived Anatomy Predicts Complexity and Hemodynamic Impact of Transcatheter Edge-to-Edge Mitral Valve Repair

89. Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin Strut Sirolimus-Eluting Coronary Stent Supraflex

90. Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study

91. Multimodality Evaluation of a Septal Cystic Cavity and Ventricular Septal Defect in the Setting of Neurocysticercosis and Endocarditis

92. Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)

93. Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub-study

94. The first multicentre study on coronary anomalies in the Netherlands

95. Feasibility and reproducibility of renal flow reserve with combined pressure and flow velocity measurements

96. Safety and feasibility evaluation of planning and execution of surgical revascularisation solely based on coronary CTA and FFR CT in patients with complex coronary artery disease: study protocol of the FASTTRACK CABG study

97. Usefulness of updated logistic clinical SYNTAX score based on MI‐SYNTAX score in patients with ST‐elevation myocardial infarction

98. The prognostic value of automated coronary calcium derived by a deep learning approach on non-ECG gated CT images from

99. One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration

100. One‐year clinical outcomes in patients with chronic kidney disease treated with COMBO stents: From the COMBO collaboration

Catalog

Books, media, physical & digital resources